Concepedia

Andy Surinach

AS

18

Publications

477

Citations

14

H-Index

2015

Active since

Affiliations

Ipsen (United States)(Current)

Pfizer (United States)

Genesis Medical Center

University of California, Los Angeles

Fred Hutch Cancer Center

Andy Surinach is an author at Ipsen (United States) specializing in medicine, outcomes research, and oncology.

ORCID

Top concepts

Publications per year

2015–2023

18

Publications

18

Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2

Manuela Di Fusco, Mary M. Moran, Alejandro Cané et al. · Journal of Medical Economics · 2021 · 56 citations · Full text

Use of the Postacute Sequelae of COVID-19 Diagnosis Code in Routine Clinical Practice in the US

Leah J. McGrath, Amie Scott, Andy Surinach et al. · JAMA Network Open · 2022 · 52 citations · Full text

Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database

Sumanta K. Pal, Jun Gong, Shivani K. Mhatre et al. · BMC Cancer · 2019 · 51 citations · Full text

Front‐line treatment patterns in multiple myeloma: An analysis of U.S.‐based electronic health records from 2011 to 2019

Shaji Kumar, Mellissa Williamson, Uzor C. Ogbu et al. · Cancer Medicine · 2021 · 41 citations · Full text

, , +20

Real-World Dosing Patterns and Outcomes of Patients With Metastatic Pancreatic Cancer Treated With a Liposomal Irinotecan Regimen in the United States

Afsaneh Barzi, Rebecca A. Miksad, Andy Surinach et al. · Pancreas · 2020 · 39 citations · Full text

Rows per page

1–5 of 18